Company / Current Assets per Share
Adaptive Biotechnologies Corp Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$2.03
FY2025
5-year range
$1.96 / $3.98
FY2021-FY2025
Trend
+3.9%
vs FY2024
Sector context
#176 of 210
Health Care
What the data says
Adaptive Biotechnologies Corp's current assets per share of $2.03 is lower than 84% of companies in the Health Care sector (FY2025). Current Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $2.03.
Based on SEC 10-K filings.
2.03 in FY2025 with a 5-year CAGR of -18.9%.
Declined from $2.87 to $2.03 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -20.1%
- 5-Year CAGR
- -18.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 210This company $2.03 Sector average $134.38
▼
-98.5% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 3.9% year-over-year.
- Ranks #176 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2019.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.03 | +3.9% |
| FY2024 | $1.96 | -31.8% |
| FY2023 | $2.87 | -27.9% |
| FY2022 | $3.98 | +35.9% |
| FY2021 | $2.93 | -49.6% |
| FY2020 | $5.80 | -87.8% |
| FY2019 | $47.71 | +233.4% |
| FY2018 | $14.31 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026